site stats

Curr cancer drug targets impact factor

WebCurr Cancer Drug Targets. 2015;15(8):739-49. doi: 10.2174/156800961508151001105814. ... These results suggest that the expression of CDK8 and its interactive genes has a profound impact on the response to adjuvant therapy in breast cancer in accordance with the role of CDK8 in chemotherapy-induced tumor … WebCurrent Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of …

Current Cancer Drug Targets Bentham Science

WebThe latest impact score (IS) of the Current Cancer Drug Targets is 2.76.It is computed in ... WebApr 7, 2024 · Journal of Drug Targeting publishes papers and reviews on all aspects of drug delivery and targeting for molecular and macromolecular drugs including the design and characterization of carrier systems (whether colloidal, protein or polymeric) for both vitro and/or in vivo applications of these drugs. Papers are not restricted to drugs delivered ... freyagyn https://azambujaadvogados.com

Current Cancer Drug Targets - Impact Factor, Overall ... - Resurchify

WebBentham Science Publishers. Bentham Science is a science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books have an ever-increasing readership of millions of researchers worldwide. WebCurrent Cancer Drug Targets is an impact factor journal that covers the full spectrum of cancer drug discovery and development for researchers and oncologists. ... Current Cancer Drug Targets. ISSN (Print): 1568-0096 ... Volume 23, Issue 2, 2024 Review Article Characteristic Hallmarks of Aging and the Impact on Carcinogenesis. Pp: 87-102 Author ... freybe cervelat salami

Current Cancer Drug Targets Impact Factor - Sci Journal

Category:Current Research in Pharmacology and Drug Discovery Journal ...

Tags:Curr cancer drug targets impact factor

Curr cancer drug targets impact factor

Current Research in Pharmacology and Drug Discovery Journal ...

WebApr 6, 2024 · Drugs. Stay up to date with the latest developments in therapeutics by reading the world’s most respected source of authoritative drug information. For 50 years Drugs has been the definitive journal of drugs and therapeutics, promoting optimum pharmacotherapy by publishing reviews and original research authored by leading international ... WebThe latest impact factor of Current Drug Therapy and all the other SCI journals was released on 30th June 2024 by Clarivate. Through this web page, researchers can check …

Curr cancer drug targets impact factor

Did you know?

WebCurrent Cancer Drug Targets is an impact factor journal that covers the full spectrum of cancer drug discovery and development for researchers and oncologists. newsletter banner. ... Researchers can access related articles from current and back volumes by purchasing access to these collections. Subscribers will also have access to new articles ... WebAbout Current Drug Targets. Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular …

WebCurrent Cancer Drug Targets. ISSN (Print): 1568-0096 ISSN (Online): 1873-5576. Volume 23 , Issues 11, 2024. This journal supports open access. Back Journal Home Submit Abstracts Submit Manuscripts. Impact Factor. Current: 2.907 5 - Year: 3.516. Ranking & Category. ONCOLOGY 140th of 222; Topic(s) Covered. WebCurrent Cancer Drug Targets is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ruiwen Zhang ( UH Drug Discovery Institute). …

WebMay 27, 2024 · The impact score (IS) 2024 of Current Cancer Drug Targets is 2.76, which is computed in 2024 as per its definition.Current Cancer Drug Targets IS is decreased … WebHeat shock factor 1 (HSF1) was discovered in 1984 as the master regulator of the heat shock response. ... Curr Cancer Drug Targets. 2024;19(7):515-524. doi: …

WebCurrent Drug Targets SJR Impact Factor 2-year, 3-year, 4-year 2-year Impact Factor. 2.843 3-year Impact Factor. 3.376 4-year Impact Factor 2.843 Scope/Description: Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins ...

WebCurrent Cancer Drug Targets is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 96. It has an SJR impact factor of 0.732 and it has a best quartile of Q2. It is published in English. It has an SJR … freyja nyitvatartásWebScope Current Cancer Drug Targets aims to cover all the latest and outstanding developments in full spectrum of cancer drug discovery and development, including but … freyholtzWebA systematic review and meta-analysis on overall survival, failure-free survival and safety outcomes in patients with metastatic hormone-sensitive prostate cancer treated with new anti-androgens. Ramos-Esquivel, Allan; Garita-Rojas, Esteban; Masis-Marroquín, Adriana. Anti-Cancer Drugs. 34 (3):405-412, March 2024. Abstract. freyja croissant szövetség utcaWebImpact Factor: 4.850 5-Year Impact Factor: 3.111 Subscribe ISSN: 2212-392X (Online) ISSN: 1574-8936 (Print) Download PDF Flyer. Abstracted & Indexed in: ... Current Cancer Drug Targets. Impact Factor: 2.907 5-Year Impact Factor: 3.516 Subscribe ISSN: 1873-5576 (Online) ISSN: 1568-0096 (Print) freyja buda nyitvatartásWebThe graph shows the changes in the impact factor of Current Cancer Drug Targets and its the corresponding percentile for the sake of comparison with the entire literature. … freyja szövetség utcaWebCurrent Cancer Drug Targets is an impact factor journal that covers the full spectrum of cancer drug discovery and development for researchers and oncologists. ... Current … freyja huld hrólfsdóttirWeb13 rows · About Current Cancer Drug Targets. Current Cancer Drug Targets aims to cover all the latest and ... freyja feh